Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients

Perirenal and subcutaneous fat differently affect outcomes in newly diagnosed classical Hodgkin lymphoma patients

“…Cachexia, that is weight loss with concomitant loss of muscle and fat mass, is highly prevalent in cancer patients and is associated with functional impairment and worse prognosis. 1,2 Body mass index (BMI) has been widely studied as a prognostic factor in patients with cHL and non-Hodgkin lymphomas with neutral, 3 negative 4 and positive 5,6 associations of higher BMI with survival being reported. Subcutaneous and visceral fat show different clinical associations in patients with metabolic diseases 7 and global measurements like BMI might not be reliable for estimation of specific body fat compartments.…”

“…Cachexia, that is weight loss with concomitant loss of muscle and fat mass, is highly prevalent in cancer patients and is associated with functional impairment and worse prognosis. 1,2 Body mass index (BMI) has been widely studied as a prognostic factor in patients with cHL and non-Hodgkin lymphomas with neutral, 3 negative 4 and positive 5,6 associ-…”